Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
The Ensign Group, Inc.
ENSG
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $9.6B
$168.22
▲ +2.06%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$134.79 - $218.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 10.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Diversified geographic footprint across 13 states with 252 operating facilities
- Integrated service delivery model combining skilled nursing with therapy and diagnostic services
- Dual revenue streams from operations and real estate leasing providing financial stability
- Established relationships with healthcare systems, insurers, and referral sources
- Operational expertise in post-acute care management and cost efficiency
Bear Case
2 risks
- Low volatility (beta 0.7).
- Premium valuation to Healthcare Facilities peers
Growth
Moderate growth ahead
Aging U.S. population increasing demand for post-acute and senior care services
Value
Premium valuation to Healthcare Facilities peers
Momentum
Weak
-16.2% over 3m
Quality
Thin
Excellent business quality
Dividend
Token
0.16% yield
Smart-money signal
Who's buying ENSG right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 23, 2026
APR 30, 2026
Reported EPS of $1.85 vs $1.79 consensus (+3.4% surprise). Revenue of $1.4B vs $1.4B expected (-0.5%).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+3.4%
Next: Apr 23, 2026
Revenue trend · last 8Q
—
—
+15%
+16%
+18%
+20%
+20%
+18%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$1.0B
$1.1B
$1.1B
$1.2B
$1.2B
$1.3B
$1.4B
$1.4B
Margins · last 8Q
Gross
21.1%
Operating
9.1%
Profit
7.2%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: RBC Capital · Jun 9, 2026